Continued">Continued">Continued">All News – Page 75 – Children Cancer Hospital Egypt 57357

All News

Cerner international continues its support and cooperation with 57357 to apply its latest informatics systems Visiting 57357, a Cerner delegation is to discuss the second phase of the development of their system to cover the Hospital’s needs and expansion December 16, 2019

Mike Pomerance, head of Cerner Middle East and Africa: I am happy with the cooperation with 57357, every time I visit the Hospital, its progress impresses me. We are not just providing an informatics system for medical care; we are looking forward to continue the journey with you. Hospital 57357’s CEO: Our reliance  on Cerner’s … Continued

His holiness Pope Tawadros II on visit to 57357

“In this place .. Egypt is beautiful” We support this great Hospital that serves the nation’s offspring and transforms dreams into reality His Holiness Pope Tawadros the Second, Pope of Alexandria and Patriarch of the See of St. Mark, expressed his satisfaction with the spirit of achievement and teamwork he touched in the Hospital “I … Continued

A Protein language: deciphering the body-microbiome cross-talk December 2, 2019

A review article recently published in in the Journal of “Proteome Research”, highlights the importance of studying the “Metaprotoeme”—the total proteins produced by the community of microbes in our bodies—in providing a vivid picture of the interaction between body cells and microbiome. Microbiome is a modern term that describes the total microbes that inhabit our … Continued

Mitochondria offers a last resort for the most aggressive of breast cancers December 1, 2019

Collaborative research between Hospital 57357 and Zewail City of Science and Technology highlights the role of mitochondria in fighting breast cancer’s resistance to chemotherapy. The study titled “Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells.”  was recently published in the  Scientific Reports, Journal on Sept, 24, … Continued

Aggresomes: A cellular indicator to predict patients’ outcomes in Pediatric Medulloblastoma November 29, 2019

Screening procedure for the presence of aggresomes could impact treatment protocols in the future In a recent study, a 57357 research team was able to detect the presence of aggresomes (aggregated protein inclusion bodies) in samples of pediatric Medulloblastoma (MB) tumors. This type of malignant brain cancer is the most common in children. The researchers were … Continued